Peter M. Castleman - 14 Aug 2026 Form 4 Insider Report for Caris Life Sciences, Inc. (CAI)

Reporting relationship: Director
Issuer ticker: CAI
Reported as of: 14 Aug 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 14 Aug 2026, 17:44:43 UTC
Prior SEC filing: 27 Feb 2026
Source filing: View source filing
Reporting owner signature: /s/ J. Russel Denton, Attorney-in-Fact

Key filing fact

Peter M. Castleman filed Form 4 for Caris Life Sciences, Inc. (CAI) on 14 Aug 2026.

Key facts

This page summarizes Peter M. Castleman's Form 4 filing for Caris Life Sciences, Inc. (CAI).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 14 Aug 2026, 17:44.

Change

Previous filing in this sequence was filed on 27 Feb 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001239594 Primary reporting owner

CASTLEMAN PETER M

Relationship: Director
Address: C/O CARIS LIFE SCIENCES, INC., 750 W. JOHN CARPENTER FREEWAY, SUITE 800, IRVING
Signature: /s/ J. Russel Denton, Attorney-in-Fact
Signature date: 14 Aug 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CAI transaction

Common Stock

Award

Transaction value
Shares: +13,192
Change %: +82%
Price: $0.000000^*
Shares after: 29,321
Date: 14 Aug 2026
Ownership: Direct
Footnotes: F1

CAI holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 108,009
Date: 14 Aug 2026
Ownership: By Family Trust

CAI holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 10,546,384
Date: 14 Aug 2026
Ownership: By CLS-PF-SPE, LLC
Footnotes: F2, F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Represents an award of restricted stock units which vest in accordance with the applicable grant agreement.

Footnote F2

Includes shares received in pro rata distributions exempt pursuant to Rule 16a-9.

Footnote F3

CLS-PF-SPE Manager, LLC is the manager of CLS-PF-SPE, LLC. Mr. Castleman is a manager of CLS-PF-SPE Manager, LLC and in such capacity has voting and investment power with respect to the shares held by CLS-PF-SPE, LLC. The Reporting Person disclaims beneficial ownership except to the extent of his pecuniary interest therein.